RIPRETINIB

UNII:	9XW757O13D
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₄H₂₁BrFN₅O₂
Preferred Substance Name:	RIPRETINIB
InChIKey:	CEFJVGZHQAGLHS-UHFFFAOYSA-N
GSRS Full Record:	9XW757O13D i

1442472-39-0
1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
DCC-2618
N-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHENYL)-N'-PHENYLUREA
QINLOCK
RIPRETINIB [MI]
RIPRETINIB [ORANGE BOOK]
RIPRETINIB [USAN]
Ripretinib [WHO-DD]
UREA, N-(4-BROMO-5-(1-ETHYL-1,2-DIHYDRO-7-(METHYLAMINO)-2-OXO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHENYL)-N'-PHENYL-
ripretinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RIPRETINIB

Synonyms and Mappings

Resources